The safety of gadolinium-based contrast agents for MRI continues to generate much controversy and discussion. As both a radiologist and a lawyer, Dr. Alexander Radbruch, JD, is well-placed to comment on the most significant recent developments in gadolinium retention in the brain, how best to use these agents, and how radiologists and manufacturers can help to avoid being sued.
The description & caption for this interview to be published online on 01.03.2019 will Philipp Ward sent directly.Video from ECR 2019: Alexander Radbruch on gadolinium debate
Feb 28, 2019
Latest in Conference
Denis Le Bihan reflects on 40 years of diffusion MRI
October 8, 2024
JFR: Private radiology group VIDI continues to expand
October 7, 2024
Privalence launches new website in time for JFR
October 4, 2024